Search company, investor...

AliveGen - Neuromuscular Assets

Founded Year



Acquired | Acquired



About AliveGen - Neuromuscular Assets

AliveGen is a privately held clinical-stage biopharmaceutical company. AliveGen focuses on the discovery and development of novel biotherrapeutics to combat the debiltating muscle and bone loss and the loss of functional capactiy, as occurs in various neuromuscular diseases, cancer cachexia, congestive heart failure, geriatric sarcopenia and frailty, as well as in other chronic diseases.

Headquarters Location

810 Lawrence Dr Suite 120

Newbury Park, California, 91320,

United States

(805) 480-9600



AliveGen - Neuromuscular Assets Frequently Asked Questions (FAQ)

  • When was AliveGen - Neuromuscular Assets founded?

    AliveGen - Neuromuscular Assets was founded in 2014.

  • Where is AliveGen - Neuromuscular Assets's headquarters?

    AliveGen - Neuromuscular Assets's headquarters is located at 810 Lawrence Dr, Newbury Park.

  • What is AliveGen - Neuromuscular Assets's latest funding round?

    AliveGen - Neuromuscular Assets's latest funding round is Acquired.

  • Who are the investors of AliveGen - Neuromuscular Assets?

    Investors of AliveGen - Neuromuscular Assets include Biogen.



CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.